本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ventyx Biosciences, Inc.

1.07
+0.01000.94%
盘后1.03-0.0400-3.74%17:21 EDT
成交量:89.76万
成交额:95.01万
市值:7,610.92万
市盈率:-0.54
高:1.10
开:1.06
低:1.03
收:1.06
数据加载中...
2024/01/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/07

重要事件披露

Form 8-K - Current report
2023/11/22

重要事件披露

Form 8-K - Current report
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/10/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/10

重要事件披露

Form 8-K - Current report
2023/10/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]